BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19545714)

  • 21. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Merli M; Nicolini G; Gentili F; Novelli G; Iappelli M; Casciaro G; Di Tondo U; Pecorella I; Marasco A; Onetti Muda A; Nudo F; Mennini G; Ginanni Corradini S; Riggio O; Berloco P; Attili AF; Rossi M
    Transplant Proc; 2005; 37(6):2535-40. PubMed ID: 16182736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.
    Baccarani U; Adani GL; Avellini C; Lorenzin D; Currò G; Beltrami A; Pasqualucci A; Bresadola V; Risaliti A; Viale PL; Beltrami CA; Bresadola F
    Transplant Proc; 2006 May; 38(4):1111-3. PubMed ID: 16757280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
    Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A
    Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
    Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M
    Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic resection for hepatocellular carcinoma meeting Milan criteria in Child-Turcotte-Pugh class a patients with cirrhosis.
    Park YK; Kim BW; Wang HJ; Kim MW
    Transplant Proc; 2009 Jun; 41(5):1691-7. PubMed ID: 19545709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].
    Fan J; Zhou J; Xu Y; Qiu SJ; Wu ZQ; Yu Y; Huang XW; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1227-31. PubMed ID: 16796876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living related liver transplantation for hepatocellular carcinoma in Egypt.
    El-Meteini M; Fayez A; Fathy M; Abdalaal A; Safaan H; Mostafa I; Abdalaal M; Mokhtar A; Salah M; El-Dorry A; Abdalwahab S; El-Monayeri M; Boillot O
    Transplant Proc; 2005 Sep; 37(7):3141-3. PubMed ID: 16213330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma.
    Karakayali H; Moray G; Sozen H; Dalgic A; Emiroglu R; Haberal M
    Transplant Proc; 2006 Mar; 38(2):575-8. PubMed ID: 16549179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. University of California at San Francisco criteria can be applied to living donor liver transplantation for hepatocellular carcinoma: single-center preliminary results in 27 patients.
    Jiang XZ; Yan LN; Wen TF; Li B; Zeng Y; Zhao JC; Wang WT; Yang JY; Xu MQ; Chen ZY; Ma YK; Li FG; Gong G
    Transplant Proc; 2008 Jun; 40(5):1476-80. PubMed ID: 18589132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria.
    Suh KS; Cho EH; Lee HW; Shin WY; Yi NJ; Lee KU
    Dig Dis; 2007; 25(4):329-33. PubMed ID: 17960068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between hepatitis B and hepatocellular carcinoma recurrence in patients undergoing liver transplantation.
    Kiyici M; Yilmaz M; Akyildiz M; Arikan C; Aydin U; Sigirli D; Nart D; Yilmaz F; Ozacar T; Karasu Z; Kilic M
    Transplant Proc; 2008 Jun; 40(5):1511-7. PubMed ID: 18589140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of liver transplantation in hepatocellular carcinoma treatment].
    Zheng SS; Wu J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):366-70. PubMed ID: 18795603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.